# Triadic Linear Attention: Three-Dimensional Recurrent States for Long-Context Sequence Modeling

Preprint · Oliver Sieberling, Bharat Runwal, David Jin, Ryan Chin, Rameswar Panda, Yoon Kim

- Archive id: arxiv:2609.36529
- Published: 2026-09-29
- arXiv: https://arxiv.org/abs/2609.36529
- Citations: 0
- Source URL: https://arxiv.org/abs/2609.36529
- PDF: https://arxiv.org/pdf/2609.36529
- Provenance: arxiv

## Abstract

Recurrent neural networks (RNNs) compress the historical context into a memory state of fixed size, thus allowing for constant-time inference. The memory state size is a crucial factor in their performance, as exemplified by the strong performance and resurgence of linear attention, which extends the vector-valued hidden states of ordinary RNNs to matrix-valued hidden states. Crucially, linear attention does so in a parameter-efficient way, in particular by using an outer product of the key and value vectors to write to the matrix-valued hidden state. We generalize this construction and propose triadic linear attention, which writes the triadic outer product of a key, a second key, and a value, into a third-order (i.e., 3D) tensor state, and reads from it by contracting both key axes with two queries. An $E$-dimensional second key thus yields an $E$-fold increase in state size while adding only two projections. Triadic linear attention is compatible with data-dependent forgetting, the delta rule, and chunkwise-parallel training. Applied to Gated DeltaNet and scalar-gated linear attention, triadic linear attention substantially improves long-context language modeling and recall, outperforming alternatives that enlarge the state.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [LLM Architectures & Pretraining](https://space-kitty.com/topics/llm-architectures)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.